ImageneBio, Inc.

IMA

ImageneBio, Inc.

IMA

Insider Sentiment (TTM):

Last Purchase:2025-12-24Last Sale:-Shares Purchased (TTM):16,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,341,607Shares Outstanding:11,211,268Institutional Ownership Pct.:47.64%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Series A Non Voting Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	-	-	0
Series A Convertible Preferred Stock	-	-	-	-	-	-	19	-	-	-	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	95	76	95	103	58	37	12	45	44	53	120	121
Property Plant And Equipment Net	-	-	0	-	0	1	0	1	1	1	2	3
Marketable Securities Current	41	41	41	39	37	77	0	93	101	104	56	76
Prepaid Expense And Other Assets Current	5	5	5	5	3	3	0	4	4	4	3	4
Temporary Equity Par Or Stated Value Per Share	-	-	0	0	-	-	0	-	-	-	-	-
Temporary Equity Shares Authorized	-	-	0	0	-	-	3	-	-	-	-	-
Temporary Equity Shares Issued	-	-	0	0	-	-	2	-	-	-	-	-
Temporary Equity Shares Outstanding	-	-	0	0	-	-	2	-	-	-	-	-
Temporary Equity Liquidation Preference	-	-	0	0	-	-	164	-	-	-	-	-
Assets Current	141	122	140	148	99	117	12	142	149	161	179	201
Operating Lease Right Of Use Asset	1	1	1	1	3	3	1	4	5	5	6	8
Other Assets Noncurrent	-	-	5	5	-	-	1	-	-	-	-	-
Assets Noncurrent
Assets	152	137	153	161	126	131	16	149	157	173	192	215
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	2	1	1	5	2	1	2	2	4
Other Long Term Debt Noncurrent	-	-	-	-	-	-	1	-	-	-	1	1
Accrued Liabilities And Other Liabilities	4	4	8	7	3	4	3	4	3	5	9	-
Deferred Revenue Current	-	-	0	0	-	-	1	-	-	-	-	-
Operating Lease Liability Current	2	2	2	2	4	4	0	4	4	3	4	3
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	-	1
Debt Current	-	-	0	0	-	-	8	-	-	-	-	-
Liabilities Current	7	7	11	11	7	9	17	9	8	10	14	19
Operating Lease Liability Noncurrent	0	0	1	1	2	3	0	4	5	6	7	8
Other Liabilities Noncurrent	1	1	1	1	1	1	0	1	1	1	-	-
Liabilities	10	13	20	21	10	13	17	15	15	17	22	28
Common Stock Value	-	-	-	-	0	0	0	0	0	0	0	0
Stockholders Equity
Liabilities Noncurrent
Preferred Stock Value	0	0	-	-	-	-	-	-	-	-	-	-
Additional Paid In Capital	393	364	363	363	459	458	2	456	455	454	452	418
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	-2	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-251	-241	-230	-223	-343	-340	-180	-322	-312	-299	-282	-263
Stockholders Equity	142	123	133	140	-180	-170	-161	-153	143	155	170	155
Temporary Equity
Redeemable Noncontrolling Interest Equity Preferre…	-	-	-	-	-	-	159	-	-	-	-	-
Redeemable Noncontrolling Interest Equity Carrying…	-	-	-	-	-	-	159	-	-	-	-	-
Liabilities And Stockholders Equity	152	137	153	161	126	131	16	149	157	173	192	215
Series A Convertible Preferred Shares	-	-	0	0	-	-	0	-	-	-	-	-
Voting Common Stock	-	0	0	0	-	-	0	-	-	-	-	-
Nonvoting Common Stock	-	0	-	-	-	-	-	-	-	-	-	-
Related Party	-	6	7	8	-	-	0	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	0	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	-	-	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	-	-	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	-	-	-	-	2	2	2	2	2	2	2	2
Shares Outstanding	-	-	-	-	2	2	2	2	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.51%	1.86%	-5.41%	-	-	-	-	-	-	-	-	-
2025	10.19%	25.93%	32.41%	-13.63%	-44.40%	-51.58%	-24.33%	-20.94%	-12.16%	-18.12%	-6.75%	-3.13%
2024	32.58%	25.76%	25.00%	4.91%	6.13%	5.52%	2.37%	-8.88%	-11.24%	-7.69%	-16.78%	-20.28%
2023	-	-	-	6.17%	-4.63%	-19.38%	12.78%	48.12%	0.75%	-2.88%	-5.04%	27.34%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	21.47	18.39	12.49	13.24	13.52	13.31	0.72	15.32	18.22	15.85	12.58	10.41
Quick Ratio	20.71	17.67	12.05	12.79	13.06	12.97	0.70	14.94	17.74	15.47	12.35	10.22
Working Capital	134.54M	115.37M	129.05M	136.39M	91.69M	108.21M	-4.74M	132.29M	141.13M	151.00M	164.46M	181.36M
Leverage & Debt
Debt to Equity	0.07	0.11	0.15	0.15	-0.06	-0.07	-0.11	-0.10	0.10	0.11	0.13	0.18
Interest Coverage TTM	-11.99	-13.97	-16.98	-55.44	-23.73	-54.92	-98.93	-1,260.74	-	-	-	-
Debt Ratio	0.07	0.10	0.13	0.13	0.08	0.10	1.10	0.10	0.09	0.10	0.12	0.13
Efficiency & Turnover
Asset Turnover TTM	0.01	0.01	0.02	0.01	0.03	0.03	0.03	0.02	0.01	0.02	0.05	0.07
Per Share Metrics
Diluted EPS TTM	-2.86	-4.18	-9.31	-7.13	-15.94	-17.20	-40.52	-37.52	-27.65	-29.05	-32.67	-28.90
Free Cash Flow Per Share TTM	-	-4.94	-9.82	-4.32	-1.00	-7.27	-17.85	-28.51	-30.21	-32.54	-38.41	-34.98
Dividend Per Share TTM	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-7,370.13%	-6,816.88%	-3,028.19%	-2,553.88%	-379.16%	-576.02%	-1,057.14%	-1,394.76%	-4,094.47%	-2,030.88%	-823.33%	-491.85%
Net Profit Margin TTM	-5,785.50%	-5,855.00%	-2,834.31%	-3,800.75%	-892.33%	-962.00%	-1,382.40%	-1,263.78%	-3,619.53%	-1,822.02%	-744.17%	-449.93%
Growth Metrics
Net Revenue Growth (1Y)	-81.40%	-81.40%	-54.29%	-61.52%	133.32%	11.78%	-61.79%	-70.20%	-90.39%	-78.08%	-41.35%	-54.08%
Net Income Growth (1Y)	20.63%	13.23%	-6.27%	15.73%	-42.48%	-40.98%	-29.02%	-16.29%	6.28%	5.97%	-0.87%	21.02%
EPS Growth (1Y)	-	-85.76%	-77.02%	-80.99%	-42.48%	1.00%	24.03%	29.81%	-13.47%	-20.38%	-14.05%	1.01%
Valuation Metrics
P/E TTM	-	-1.20	-0.74	-1.14	-1.01	-0.52	-0.49	-0.55	-0.72	-0.59	-0.72	-1.80
P/B TTM	-	0.45	0.25	0.50	-0.22	-0.13	-0.15	-0.19	0.33	0.26	0.29	0.73
P/S TTM	-	70.07	21.01	43.43	9.02	5.04	6.71	6.99	25.92	10.69	5.39	8.09
Market Cap	-	56.06M	33.61M	69.49M	38.80M	21.66M	23.50M	29.08M	47.78M	41.12M	49.33M	112.85M
Enterprise Value	-	-19.99M	-60.92M	-33.67M	-19.49M	-15.11M	18.88M	-16.11M	2.23M	-13.01M	-71.84M	-9.70M
Calculated Values
Free Cash Flow TTM	-45.02M	-55.41M	-47.84M	-36.87M	-2.41M	-10.25M	-21.32M	-39.93M	-72.88M	-78.53M	-80.16M	-75.96M
Net Debt	-94.68M	-76.05M	-94.53M	-103.16M	-58.29M	-36.76M	-4.62M	-45.19M	-45.55M	-54.13M	-121.17M	-122.56M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-24Purchase

Owner: Slattery, Joseph P

Title: -

Shares: 16,000

Price/Share: $5.99

Value: $95,840.00

Shares Owned: 16,000

Relationship: Director

Ownership: Direct

2025-07-25Purchase

Owner: Bonita, David P

Title: -

Shares: 83,611

Price/Share: $29.90

Value: $2,499,968.90

Shares Owned: 287,885

Relationship: Director

Ownership: Indirect

2025-07-25Purchase

Owner: Stampacchia, Otello

Title: -

Shares: 267,556

Price/Share: $29.90

Value: $7,999,924.40

Shares Owned: 454,982

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-24	Slattery, Joseph P	Director	-	Direct	Purchase	16,000	5.99	$95,840.00	16,000	4
2025-07-25	Bonita, David P	Director	-	Indirect	Purchase	83,611	29.90	$2,499,968.90	287,885	4
2025-07-25	Stampacchia, Otello	Director	-	Indirect	Purchase	267,556	29.90	$7,999,924.40	454,982	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

47.64%

Inst. Shares: 5,341,607

Shares Outstanding: 11,211,268

2025-12-31

97.25%

Inst. Shares: 4,736,777

Shares Outstanding: 4,870,906

2025-09-30

55.18%

Inst. Shares: 4,705,090

Shares Outstanding: 8,526,781

2025-06-30

65.25%

Inst. Shares: 31,487,857

Shares Outstanding: 48,258,111

2025-03-31

Inst. Shares: 32,472,199

Shares Outstanding: 1,409,963

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,341,607	11,211,268	47.64%
2025-12-31	4,736,777	4,870,906	97.25%
2025-09-30	4,705,090	8,526,781	55.18%
2025-06-30	31,487,857	48,258,111	65.25%
2025-03-31	32,472,199	1,409,963	-
2024-12-31	31,227,708	1,194,172	-
2024-09-30	27,655,911	1,400,557	-
2024-06-30	28,426,540	48,258,111	58.91%
2024-03-31	28,547,795	48,258,111	59.16%
2023-12-31	30,810,242	41,735,081	73.82%
2023-09-30	30,594,860	43,437,844	70.43%
2023-06-30	29,104,199	39,292,710	74.07%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ImageneBio, Inc. (IMA) — SEC Financial Statements & Analysis

ImageneBio, Inc. (IMA) is a biological products, (no diagnostic substances) company, incorporated in DE. ImageneBio, Inc. trades on Nasdaq as: IMA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ImageneBio, Inc. reported a -81.40% year-over-year revenue growth, a Debt-to-Equity ratio of 0.07x, a Price-to-Sales (P/S) ratio of 70.07x (TTM), a Price-to-Book (P/B) ratio of 0.45x (TTM), at a market cap of $56.06M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -81.40%
Debt To Equity: 0.07x
P/S TTM: 70.07x
P/B TTM: 0.45x
Market Cap: $56.06M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ImageneBio, Inc. in?

ImageneBio, Inc. (IMA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is IMA's market cap?

ImageneBio, Inc. (IMA) has a market capitalization of $56.06M as of 2026-03-31.

What exchange does IMA trade on?

ImageneBio, Inc. (IMA) trades on the Nasdaq.

Where is ImageneBio, Inc. incorporated?

ImageneBio, Inc. is incorporated in DE.

ImageneBio, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

ImageneBio, Inc. (IMA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

ImageneBio, Inc. (IMA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.